Executive summary

Based on six original studies including 816 glioblastoma multiforme patients, this comprehensive synthesis of data performed by a Bayesian network meta-analysis showed that PT demonstrated the highest probability of being associated with the best OS (SUCRA: 72.6%), followed by VMAT (SUCRA: 66.5%) and IMRT (SUCRA:44.9), whereas 3DCRT was least likely to be the optimal treatment strategy (SUCRA: 26.3%). PT was the most likely regimen yielding a higher PFS with estimated SUCRA values of 78.25%, followed by IMRT with 57%. 

Key content topics
Top cancer treatments